or Try an Advanced Search...

    Technical Analysis for RGT - Argent Biopharma Limited

    Grade Last Price % Change Price Change
    A 0.535 -0.93% -0.005
    RGT closed down 0.93 percent on Thursday, October 3, 2024, on 1.25 times normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong N/A Up Up
    Historical RGT trend table...
    Date Alert Name Type % Chg
    180 Bullish Setup Bullish Swing Setup 0.00%
    Upper Bollinger Band Walk Strength 0.00%
    Wide Bands Range Expansion 0.00%
    Above Upper BB Strength 0.00%
    Overbought Stochastic Strength 0.00%
    Upper Bollinger Band Touch Strength 0.00%
    Gapped Down Weakness 0.00%
    New 52 Week Closing High Bullish -0.93%
    Pocket Pivot Bullish Swing Setup -0.93%
    New 52 Week High Strength -0.93%
    Older End-of-Day Signals for RGT ...

       Recent Intraday Alerts

    Alert Time
    Down 10% about 15 hours ago
    Down 1 ATR about 15 hours ago
    3x Volume Pace about 15 hours ago
    2x Volume Pace about 15 hours ago
    1.5x Volume Pace about 15 hours ago
    View Earlier Intraday Alerts

    Get a Trading Assistant

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    RGT Chart by TradingView
    Basic chart:

    Profile

    Argent BioPharma Limited, a drug discovery clinical-stage biopharmaceutical company, provides medicines targeting immunology and neurology worldwide. Its principal product candidates include CimetrA, which is in phase II clinical trial for the treatment of SLE Lupus, anti-inflammatory, and SARS COVID-19; and CannEpil, which is in phase I clinical trial for refractory epilepsy and cerebral palsy; and CogniCann, which is in phase I clinical trial for the symptomatic relief of Dementia and Alzheimer. In addition, the company provides Irnican for brain cancer. The company was formerly known as MGC Pharmaceuticals Limited and changed it name to Argent BioPharma Limited. Argent BioPharma Limited was founded in 2014 and is based in Subiaco, Australia.
    Classification
    Sector: Healthcare
    Industry: Drug Manufacturers - Specialty & Generic
    Keywords: Biopharmaceutical Drug Discovery Dementia Brain Cancer Cerebral Palsy

    Is RGT a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 0 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 0.57
    52 Week Low 0.15
    Average Volume 72,768
    200-Day Moving Average 0.000
    50-Day Moving Average 0.322
    20-Day Moving Average 0.361
    10-Day Moving Average 0.389
    Average True Range 0.043
    RSI (14) 75.31
    ADX 33.23
    +DI 48.120
    -DI 24.468
    Chandelier Exit (Long, 3 ATRs) 0.441
    Chandelier Exit (Short, 3 ATRs) 0.419
    Upper Bollinger Bands 0.511
    Lower Bollinger Band 0.210
    Percent B (%b) 1.08
    BandWidth 83.384
    MACD Line 0.044
    MACD Signal Line 0.020
    MACD Histogram 0.024
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.648
    Resistance 3 (R3) 0.635 0.585 0.629
    Resistance 2 (R2) 0.585 0.556 0.591 0.622
    Resistance 1 (R1) 0.560 0.539 0.573 0.573 0.616
    Pivot Point 0.510 0.510 0.516 0.516 0.510
    Support 1 (S1) 0.485 0.481 0.498 0.498 0.454
    Support 2 (S2) 0.435 0.464 0.441 0.448
    Support 3 (S3) 0.410 0.435 0.441
    Support 4 (S4) 0.423